Skip to content

Drug interactions

Efavirenz + Eltrombopag

Severity: Minor

Efavirenz and Eltrombopag: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

The mechanism proposed for this pair is unclear. Efavirenz is not a clinically important CYP2C9 inhibitor, and it is more often an inducer, so a significant rise in eltrombopag exposure is not well supported.

What this interaction means in plain words

Efavirenz and Eltrombopag have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Efavirenz belongs to Anti Virals; Eltrombopag belongs to Miscellaneous.

Evidence level: Low

Why it happens

No well-established mechanism; any effect would be indirect via enzyme induction.

What to do

No dose change is routinely needed. Monitor platelet counts and liver tests, since both drugs can affect hepatic function.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Eltrombopag, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Eltrombopag?

MediHelp rates the interaction as minor. Efavirenz and Eltrombopag have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. The mechanism proposed for this pair is unclear. Efavirenz is not a clinically important CYP2C9 inhibitor, and it is more often an inducer, so a significant rise in eltrombopag exposure is not well supported.

How serious is the interaction between Efavirenz and Eltrombopag?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is routinely needed. Monitor platelet counts and liver tests, since both drugs can affect hepatic function.

What other medicines interact with Efavirenz?

MediHelp also lists interactions of Efavirenz with, for example, Cobimetinib, Dienogest / estradiol valerate, Dihydroergotamine intranasal. The full list is on the Efavirenz page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in